Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,440 across all filing types
Latest filing 2023-10-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事对第七届董事会第六次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing prior approval opinions related to the company's board meeting, specifically about the reappointment of an audit firm for the 2023 financial audit and internal control audit. It references governance rules and the audit firm but does not contain any financial statements or audit results itself. The document is short (604 characters) and serves as a formal opinion or announcement related to board management matters rather than a full audit report or annual report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or approvals related to the company's board or senior management.
2023-10-30 Chinese
关于召开2023年第一次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2023 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It details the meeting date, voting procedures, registration methods, and agenda items for shareholder approval. There is no financial data or report content included, only procedural and logistical information about the meeting. The document is relatively short (3784 characters) and serves as an announcement for the meeting rather than the meeting materials or results themselves. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2023-10-30 Chinese
独立董事对第七届董事会第六次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on the company's 2023 third quarter report and the reappointment of the auditing firm. It references the 2023 third quarter report but does not contain the report itself or detailed financial data. The document is short (905 characters) and serves as an opinion or certification related to the report and audit firm reappointment. It fits the category of Regulatory Filings (RNS) as it is a formal attestation and opinion rather than the financial report itself.
2023-10-30 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the seventh board of directors of the company. It includes details about the meeting date, voting results on various proposals including approval of the 2023 third quarter report, reappointment of the accounting firm, and the proposal to convene an extraordinary general meeting. The document does not contain the actual financial report or detailed financial data but refers to the 2023 third quarter report and other announcements published elsewhere. The document is primarily a board meeting resolution announcement and does not qualify as an Interim/Quarterly Report (IR) itself. It is also not a full Annual Report or Audit Report. Given the nature of the content, it fits best under Board/Management Information (MANG) as it relates to board meeting decisions and management matters.
2023-10-30 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2023 年半年度报告全文" which translates to "2023 Semi-Annual Report Full Text". It contains detailed financial data, management discussion and analysis, company governance, environmental and social responsibility, and other comprehensive sections typical of an interim or quarterly report. The report covers the period from January 1, 2023 to June 30, 2023, which is a half-year period. The document length is substantial (15,000 characters), and it includes actual financial statements and substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-08-30 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the first half of 2023, including balances, interest, repayments, and relationships with related parties. It includes financial data for the half-year period and is approved by the board on August 30, 2023. The content is financial and operational in nature, covering a period shorter than a full fiscal year, and contains substantive financial data and analysis. It is not a brief announcement or a certification letter, nor is it a full annual report or earnings release. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-08-30 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.